Unknown

Dataset Information

0

Inflammatory bowel disease patient concerns and experiences on transition to home-based infusions during the COVID-19 pandemic.


ABSTRACT:

Background

In response to the COVID-19 pandemic, the CDC issued guidance advising patients and providers to adopt social distancing practices such as home-based infusions (H-BI).

Methods

We performed a mixed methods evaluation to summarize perceptions, concerns, and experiences with H-BI among all inflammatory bowel disease patients 18-90 years of age who transitioned to home-based infliximab or vedolizumab infusions between March to July 2020 at a tertiary care center. Semi-structured interviews were conducted and analyzed using an iterative, inductive thematic approach. Baseline characteristics and outcome on safety, COVID-19 transmission, delays in infusions, and H-BI persistence were collected.

Results

Of the 57 participants who transitioned to H-BI, 20 (33%) responded. Four major categories and six major themes related to expectations, experience, perceived safety, and logistical factors were identified. Initial perceptions were mixed, however these resolved. One patient developed COVID-19, one patient experienced an adverse event, 12 (21%) patients experienced an infusion delay, and 6 (11%) patients transitioned from H-BI.

Discussion

Despite mixed initial perceptions, respondents had a positive experience with most respondents planning to continue H-BI after the pandemic resolves. Several real-world actionable barriers were identified related to scheduling, communication between stakeholders, and nursing quality. No major safety concerns were identified.

SUBMITTER: Jacob J 

PROVIDER: S-EPMC9238022 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inflammatory bowel disease patient concerns and experiences on transition to home-based infusions during the COVID-19 pandemic.

Jacob Janson J   Aintabi Daniel D   DeJonckheere Melissa M   Cohen-Mekelburg Shirley A SA   Allen John I JI   Irani David N DN   Fendrick A Mark AM   Waljee Akbar K AK   Higgins Peter D R PDR   Berinstein Jeffrey A JA  

Research in social & administrative pharmacy : RSAP 20220628 12


<h4>Background</h4>In response to the COVID-19 pandemic, the CDC issued guidance advising patients and providers to adopt social distancing practices such as home-based infusions (H-BI).<h4>Methods</h4>We performed a mixed methods evaluation to summarize perceptions, concerns, and experiences with H-BI among all inflammatory bowel disease patients 18-90 years of age who transitioned to home-based infliximab or vedolizumab infusions between March to July 2020 at a tertiary care center. Semi-struc  ...[more]

Similar Datasets

| S-EPMC8600957 | biostudies-literature
| S-EPMC9713627 | biostudies-literature
| S-EPMC8452509 | biostudies-literature
| S-EPMC8530243 | biostudies-literature
| S-EPMC11236464 | biostudies-literature
| S-EPMC9906129 | biostudies-literature
| S-EPMC7162648 | biostudies-literature
| S-EPMC7337669 | biostudies-literature
| S-EPMC8193011 | biostudies-literature
| S-EPMC10186967 | biostudies-literature